Samsung Bioepis and Teva Enter Into a Strategic Partnership for Commercialization of EPYSQLI (Eculizumab-aagh) in the United States
Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far
Sector Update: Health Care Stocks Advance Late Afternoon
Catalyst Pharmaceuticals Jumps 14% on Firdapse Settlement With Teva
Express News | Catalyst Pharmaceuticals Inc - Penging Firdapse Patent Litigation Against Hetero and Lupin Ongoing
Catalyst Pharmaceuticals Announces Settlement Of FIRDAPSE Patent Litigation With Teva Pharmaceuticals; Teva Will Not Market Its Generic Version Of FIRDAPSE In The U.S. Any Earlier Than February 25, 2035, If Approved By The FDA
Mangkawat : red day but its still stable
Jaguar8 OP Mangkawat : Nothing big news for me on this one unless it comes with a monetary award
Mangkawat Jaguar8 OP : how about $BioLine Rx (BLRX.US)$ bioline rx. any news ? drop and drop.
Jaguar8 OP Mangkawat : It made an offering days ago
Mangkawat Jaguar8 OP : but price look like on risk to be delist. still below $1 .
View more comments...